These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39372927)

  • 1. The
    Lange LM; Levine K; Fox SH; Marras C; Ahmed N; Kuznetsov N; Vitale D; Iwaki H; Lohmann K; Marsili L; Espay AJ; Bauer P; Beetz C; Martin J; Factor SA; Higginbotham LA; Chen H; Leonard H; Nalls M; Mencacci NE; Morris HR; Klein C; Blauwendraat C; Fang ZH;
    Res Sq; 2024 Sep; ():. PubMed ID: 39372927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p.L1795F LRRK2 variant is a common cause of Parkinson's disease in Central Europe.
    Ostrozovicova M; Tamas G; Dušek P; Grofik M; Han V; Holly P; Jech R; Kalinova K; Klivenyi P; Kovacs N; Kulcsarova K; Kurca E; Lackova A; Lee H; Lewis P; Magocova V; Marekova M; Murphy D; Necpal J; Pinter D; Rabajdova M; Růžička E; Serranova T; Smilowska K; Soos K; Straka I; Svorenova T; Valkovic P; Zarubova K; Gdovinova Z; Houlden H; Rizig M; Skorvanek M
    Res Sq; 2024 May; ():. PubMed ID: 38854119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
    Gustavsson EK; Follett J; Trinh J; Barodia SK; Real R; Liu Z; Grant-Peters M; Fox JD; Appel-Cresswell S; Stoessl AJ; Rajput A; Rajput AH; Auer R; Tilney R; Sturm M; Haack TB; Lesage S; Tesson C; Brice A; Vilariño-Güell C; Ryten M; Goldberg MS; West AB; Hu MT; Morris HR; Sharma M; Gan-Or Z; Samanci B; Lis P; Periñan MT; Amouri R; Ben Sassi S; Hentati F; ; Tonelli F; Alessi DR; Farrer MJ
    Lancet Neurol; 2024 Jun; 23(6):603-614. PubMed ID: 38614108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pathogenic variant in RAB32 causes autosomal dominant Parkinson's disease and activates LRRK2 kinase.
    Gustavsson EK; Follett J; Trinh J; Barodia SK; Real R; Liu Z; Grant-Peters M; Fox JD; Appel-Cresswell S; Stoessl AJ; Rajput A; Rajput AH; Auer R; Tilney R; Sturm M; Haack TB; Lesage S; Tesson C; Brice A; Vilariño-Güell C; Ryten M; Goldberg MS; West AB; Hu MT; Morris HR; Sharma M; Gan-Or Z; Samanci B; Lis P; Tocino T; Amouri R; Sassi SB; Hentati F; ; Tonelli F; Alessi DR; Farrer MJ
    medRxiv; 2024 Jan; ():. PubMed ID: 38293014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson's disease cohort.
    Bryant N; Malpeli N; Ziaee J; Blauwendraat C; Liu Z; ; West AB
    Hum Mol Genet; 2021 Apr; 30(6):454-466. PubMed ID: 33640967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations.
    Rizig M; Bandres-Ciga S; Makarious MB; Ojo O; Crea PW; Abiodun O; Levine KS; Abubakar S; Achoru C; Vitale D; Adeniji O; Agabi O; Koretsky MJ; Agulanna U; Hall DA; Akinyemi R; Xie T; Ali M; Shamim EA; Ani-Osheku I; Padmanaban M; Arigbodi O; Standaert DG; Bello A; Dean M; Erameh C; Elsayed I; Farombi T; Okunoye O; Fawale M; Billingsley KJ; Imarhiagbe F; Jerez PA; Iwuozo E; Baker B; Komolafe M; Malik L; Nwani P; Daida K; Nwazor E; Miano-Burkhardt A; Nyandaiti Y; Fang ZH; Obiabo Y; Kluss JH; Odeniyi O; Hernandez D; Odiase F; Tayebi N; Ojini F; Sidranksy E; Onwuegbuzie G; D'Souza AM; Osaigbovo G; Berhe B; Osemwegie N; Reed X; Oshinaike O; Leonard H; Otubogun F; Alvarado CX; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Iwaki H; Kim JJ; Morris HR; Hardy J; Nalls M; Heilbron K; Norcliffe-Kaufmann L; ; Blauwendraat C; Houlden H; Singleton A; Okubadejo N
    medRxiv; 2023 May; ():. PubMed ID: 37398408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
    Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
    Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant Parkinson's disease caused by the recently identified LRRK2 N1437D mutation in a Chinese family: Clinical features, imaging findings, and functional impact.
    Sun YM; Gan LH; Peng F; Zhou XY; Chen QS; Liu FT; Tang YL; Wu P; Lu JY; Ge JJ; Yen TC; Zuo CT; Song B; Wu JJ; Wang J
    Parkinsonism Relat Disord; 2023 Jun; 111():105441. PubMed ID: 37201327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding.
    Kalogeropulou AF; Purlyte E; Tonelli F; Lange SM; Wightman M; Prescott AR; Padmanabhan S; Sammler E; Alessi DR
    Biochem J; 2022 Sep; 479(17):1759-1783. PubMed ID: 35950872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort.
    Usnich T; Vollstedt EJ; Schell N; Skrahina V; Bogdanovic X; Gaber H; Förster TM; Heuer A; Koleva-Alazeh N; Csoti I; Basak AN; Ertan S; Genc G; Bauer P; Lohmann K; Grünewald A; Schymanski EL; Trinh J; Schaake S; Berg D; Gruber D; Isaacson SH; Kühn AA; Mollenhauer B; Pedrosa DJ; Reetz K; Sammler EM; Valente EM; Valzania F; Volkmann J; Zittel S; Brüggemann N; Kasten M; Rolfs A; Klein C;
    Front Neurol; 2021; 12():710572. PubMed ID: 34475849
    [No Abstract]   [Full Text] [Related]  

  • 12. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.
    Trinh J; Gustavsson EK; Vilariño-Güell C; Bortnick S; Latourelle J; McKenzie MB; Tu CS; Nosova E; Khinda J; Milnerwood A; Lesage S; Brice A; Tazir M; Aasly JO; Parkkinen L; Haytural H; Foroud T; Myers RH; Sassi SB; Hentati E; Nabli F; Farhat E; Amouri R; Hentati F; Farrer MJ
    Lancet Neurol; 2016 Nov; 15(12):1248-1256. PubMed ID: 27692902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
    Cook L; Verbrugge J; Schwantes-An TH; Schulze J; Foroud T; Hall A; Marder KS; Mata IF; Mencacci NE; Nance MA; Schwarzschild MA; Simuni T; Bressman S; Wills AM; Fernandez HH; Litvan I; Lyons KE; Shill HA; Singer C; Tropea TF; Vanegas Arroyave N; Carbonell J; Cruz Vicioso R; Katus L; Quinn JF; Hodges PD; Meng Y; Strom SP; Blauwendraat C; Lohmann K; Casaceli C; Rao SC; Ghosh Galvelis K; Naito A; Beck JC; Alcalay RN
    Brain; 2024 Aug; 147(8):2668-2679. PubMed ID: 39074992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson's disease.
    William MB; Hamed S; Shalash A; Khedr EM; Yousef MH; El-Jaafary S; Fawi G; Helmy A; Hamid E; Essam M; Lee H; Jama A; Koraym M; Mahmoud DM; Elfarrash S; Elsaid Y; Gabr AS; Shebl N; Abdelwahhab N; Belal TM; Elsayed NAB; El-Gamal M; Elgamal S; Ragab S; Mekky J; Aly L; Nabhan S; Ragab G; Hussein MA; Hegazy MT; Houlden H; Salama M; Rizig M
    NPJ Parkinsons Dis; 2024 Nov; 10(1):215. PubMed ID: 39505921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional variants in the
    Hui KY; Fernandez-Hernandez H; Hu J; Schaffner A; Pankratz N; Hsu NY; Chuang LS; Carmi S; Villaverde N; Li X; Rivas M; Levine AP; Bao X; Labrias PR; Haritunians T; Ruane D; Gettler K; Chen E; Li D; Schiff ER; Pontikos N; Barzilai N; Brant SR; Bressman S; Cheifetz AS; Clark LN; Daly MJ; Desnick RJ; Duerr RH; Katz S; Lencz T; Myers RH; Ostrer H; Ozelius L; Payami H; Peter Y; Rioux JD; Segal AW; Scott WK; Silverberg MS; Vance JM; Ubarretxena-Belandia I; Foroud T; Atzmon G; Pe'er I; Ioannou Y; McGovern DPB; Yue Z; Schadt EE; Cho JH; Peter I
    Sci Transl Med; 2018 Jan; 10(423):. PubMed ID: 29321258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
    Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis and natural history of Parkinson's disease due to the LRRK2 G2019S variant.
    Kmiecik MJ; Micheletti S; Coker D; Heilbron K; Shi J; Stagaman K; Filshtein Sonmez T; Fontanillas P; Shringarpure S; Wetzel M; Rowbotham HM; Cannon P; Shelton JF; Hinds DA; Tung JY; ; Holmes MV; Aslibekyan S; Norcliffe-Kaufmann L
    Brain; 2024 Jun; 147(6):1996-2008. PubMed ID: 38804604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population.
    Zhao Y; Qin L; Pan H; Liu Z; Jiang L; He Y; Zeng Q; Zhou X; Zhou X; Zhou Y; Fang Z; Wang Z; Xiang Y; Yang H; Wang Y; Zhang K; Zhang R; He R; Zhou X; Zhou Z; Yang N; Liang D; Chen J; Zhang X; Zhou Y; Liu H; Deng P; Xu K; Xu K; Zhou C; Zhong J; Xu Q; Sun Q; Li B; Zhao G; Wang T; Chen L; Shang H; Liu W; Chan P; Xue Z; Wang Q; Guo L; Wang X; Xu C; Zhang Z; Chen T; Lei L; Zhang H; Wang C; Tan J; Yan X; Shen L; Jiang H; Zhang Z; Hu Z; Xia K; Yue Z; Li J; Guo J; Tang B
    Brain; 2020 Jul; 143(7):2220-2234. PubMed ID: 32613234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson's disease.
    Rizig M; Ojo OO; Athanasiou-Fragkouli A; Agabi OP; Oshinaike OO; Houlden H; Okubadejo NU
    Neurobiol Aging; 2021 Mar; 99():101.e15-101.e19. PubMed ID: 33158606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-tracer PET correlation analysis reveals disease-specific patterns in Parkinson's disease and asymptomatic LRRK2 pathogenic variant carriers compared to healthy controls.
    Mannheim JG; Fu JF; Wegener T; Klyuzhin IS; Vafai N; Shahinfard E; McKenzie J; Strongosky A; Wszolek ZK; Jon Stoessl A; Sossi V
    Neuroimage Clin; 2024; 42():103600. PubMed ID: 38599001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.